Leading science, pioneering therapies
CRM Publications

Marketing of unproven stem cell-based interventions: A call to action.

TitleMarketing of unproven stem cell-based interventions: A call to action.
Publication TypeJournal Article
Year of Publication2017
AuthorsSipp D, Caulfield T, Kaye J, Barfoot J, C Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ
JournalSci Transl Med
Volume9
Issue397
Date Published2017 Jul 05
ISSN1946-6242
Abstract

Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.

DOI10.1126/scitranslmed.aag0426
Alternate JournalSci Transl Med
PubMed ID28679655
Publication institute
CRM